April 2025 Newsletter
This month, we delve into one of the most groundbreaking developments in melanoma research: vaccines. Our spotlight article examines the potential of mRNA…
April 2025 Newsletter
This month, we delve into one of the most groundbreaking developments in melanoma research: vaccines. Our spotlight article examines the potential of mRNA…
AYA Cancer Conversation: Navigating Young Adult Cancer
We’re excited to share the latest episode of the AIM at Melanoma podcast, featuring an inspiring conversation with Abby Singh,…
,
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
…NSCLC. Improved Survival in Patients with Metastatic Melanoma Patients with metastatic melanoma who received a COVID-19 mRNA vaccine within 100…
,
Young Adult Cancer & Mental Health
In this episode of Beyond the Clinic: Living Well with Melanoma, host Dr. Samantha Siegel sits down with Dr. Victoria…
,
Advocates Renew Call for RP1 Approval
As the U.S. Food and Drug Administration approaches a pivotal decision on a potential new treatment for advanced melanoma, patient…
,
Grocery Shopping Tips for Melanoma Caregivers
…to keep the food at a safe temperature until you make it home. Check the dates: Melanoma patients often have decreased…
,
Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
,
Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
,
Melanoma and Body Image
Facing melanoma or any cancer isn’t just a physical journey — it impacts your mind, emotions, relationships, and sense of…
,
One Day at a Time: Caregiving Through Ocular Melanoma
In this episode, we sit down with Vanessa Tompkins, wife and caregiver to Mike, who has been battling Stage IV…
,
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026